Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study

PURPOSE: Hepatic injury is a common side effect following tyrosine kinase inhibitor (TKI) therapy and our understanding usually comes from clinical trials. In this retrospective study, we aimed to investigate the characteristics, risk factors and regimen-related differences of epidermal growth facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jie, Zhang, Xueyan, Zhang, Bo, Yan, Bo, Wang, Lin, Gu, Ping, Wang, Weimin, Wang, Huimin, Han, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227784/
https://www.ncbi.nlm.nih.gov/pubmed/32494193
http://dx.doi.org/10.2147/CMAR.S237968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227784/
https://www.ncbi.nlm.nih.gov/pubmed/32494193
http://dx.doi.org/10.2147/CMAR.S237968

Ejemplares similares